Institutional Biosafety Committee
The University of Vermont (UVM), in accordance with the Department of Health and Human Services Guidelines for Research Involving Recombinant DNA Molecules, has established an Institutional Biosafety Committee (IBC) to oversee research that involves Recombinant DNA, Infectious Agents and toxins at this institution. All faculty, staff, students or users of the facilities at UVM who are contemplating use of recombinant DNA research must comply with these Guidelines. All protocols, in which recombinant DNA will be used, regardless of the funding source, must be submitted to the Institutional Biosafety Committee for review.
The IBC is reviewing the use of infectious agents in addition to the use of recombinant DNA. We are currently revising our forms, guidelines and processes in preparation for this. Risk Management will continue to oversee chemical and biological safety.
|INSTITUTIONAL BIOSAFETY COMMITTEE||Tel: (802) 656-5040|
|University of Vermont - Research Protections Office||Email: email@example.com|
|213 Waterman Building|
|85 South Prospect Street|
|Burlington, VT 05405|
Last modified June 27 2011 12:36 PM